Curis (FRA:CUS0) Net Interest Margin (Bank Only) %


FRA:CUS0 Curis Inc FRA:CUS0
59 GF Score
Price €0.40
GF Value €0.79
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Curis Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

FRA:CUS0
59GF Score
Curis Inc FRA:CUS0
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Curis (FRA:CUS0) Overvalued in 2026?

Based on GuruFocus' analysis, Curis stock appears to be undervalued. The current stock price of €0.40 is trading 49.4% below its estimated GF Value™ of €0.79. GuruFocus considers Curis to be Possible Value Trap.

Key valuation signals for FRA:CUS0:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: €0.79 vs. price of €0.40 (49.4% below fair value)
  • GF Score™: 59/100 with 5 warning signs

No single metric tells the full story. See the FRA:CUS0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Curis Business Description

Other Exchanges CRIS:USA
Address 128 Spring Street, Building C - Suite 500, Lexington, MA, USA, 02421
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
59GF Score

Get the complete analysis for FRA:CUS0

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.40
Price
€0.79
GF Value